NYSE:RAD

Rite Aid Stock Forecast, Price & News

$18.25

-0.19 (-1.03 %)

(As of 01/15/2021 12:00 AM ET)

Add

Compare

Today's Range

$18.17

Now: $18.25▼

$18.71

50-Day Range

$13.20

MA: $16.89▼

$20.08

52-Week Range

$8.85

Now: $18.25▼

$22.45

Volume2.10 million shs

Average Volume2.71 million shs

Market Capitalization$1.01 billion

P/E RatioN/A

Dividend YieldN/A

Beta0.79

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and provides preventative services, such as screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order and specialty pharmacy services, as well as drug benefits under the federal government's Medicare Part D program. As of April 21, 2020, the company operated approximately 2,400 retail pharmacy locations in 18 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

MarketRank^™

Overall MarketRank^™

0.97 out of 5 stars

Retail/Wholesale Sector

212th out of 333 stocks

Drug Stores & Proprietary Stores Industry

7th out of 12 stocks

0.9 Analyst's Opinion

Consensus Rating
Rite Aid has received a consensus rating of Hold. The company's average rating score is 1.75, and is based on no buy ratings, 3 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $13.33, Rite Aid has a forecasted downside of 26.9% from its current price of $18.25.
Amount of Analyst Coverage
Rite Aid has only been the subject of 1 research reports in the past 90 days.

2.5 Community Rank

Outperform Votes
Rite Aid has received 788 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Rite Aid has received 798 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Rite Aid has received 50.32% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote “Outperform” if you believe RAD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Rite Aid does not currently pay a dividend.
Dividend Growth
Rite Aid does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Rite Aid insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.52% of the stock of Rite Aid is held by insiders.
Percentage Held by Institutions
59.71% of the stock of Rite Aid is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Rite Aid are expected to grow in the coming year, from ($0.07) to $0.17 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Rite Aid is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Rite Aid is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Rite Aid has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Drug stores & proprietary stores

Sub-IndustryDrug Retail

SectorRetail/Wholesale

Current SymbolNYSE:RAD

Previous Symbol

CUSIP76775410

CIK84129

Webwww.riteaid.com

Phone717-761-2633

Employees29,840

Debt

Debt-to-Equity Ratio5.84

Current Ratio1.58

Quick Ratio0.82

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$21.93 billion

Price / Sales0.05

Cash Flow$11.27 per share

Price / Cash Flow1.62

Book Value$10.92 per share

Price / Book1.67

Profitability

EPS (Most Recent Fiscal Year)$0.15

Net Income$-452,170,000.00

Net Margins-1.51%

Return on Equity2.86%

Return on Assets0.21%

Miscellaneous

Outstanding Shares55,224,000

Market Cap$1.01 billion

Next Earnings Date4/15/2021 (Estimated)

OptionableOptionable

$18.25

-0.19 (-1.03 %)

(As of 01/15/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.

Rite Aid (NYSE:RAD) Frequently Asked Questions

How has Rite Aid's stock been impacted by COVID-19?

Rite Aid's stock was trading at $14.13 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RAD stock has increased by 29.2% and is now trading at $18.25.
View which stocks have been most impacted by COVID-19.

Is Rite Aid a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Rite Aid stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RAD, but not buy additional shares or sell existing shares.
View analyst ratings for Rite Aid or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Rite Aid?

Wall Street analysts have given Rite Aid a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Rite Aid wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release its next quarterly earnings announcement on Thursday, April 15th 2021.
View our earnings forecast for Rite Aid.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) announced its quarterly earnings results on Wednesday, December, 16th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.05) by $0.45. The business earned $6.12 billion during the quarter, compared to analyst estimates of $5.84 billion. Rite Aid had a positive return on equity of 2.86% and a negative net margin of 1.51%. Rite Aid's quarterly revenue was up 12.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.54 EPS.
View Rite Aid's earnings history.

When did Rite Aid's stock split? How did Rite Aid's stock split work?

Shares of Rite Aid reverse split on the morning of Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid updated its fourth quarter earnings guidance on Thursday, December, 17th. The company provided EPS guidance of -($0.16)-0.24 for the period, compared to the Thomson Reuters consensus estimate of ($0.25). The company issued revenue guidance of $5.77-6.07 billion, compared to the consensus revenue estimate of $5.90 billion.

What price target have analysts set for RAD?

4 brokerages have issued 1-year price objectives for Rite Aid's stock. Their forecasts range from $6.00 to $17.00. On average, they expect Rite Aid's stock price to reach $13.33 in the next twelve months. This suggests that the stock has a possible downside of 26.9%.
View analysts' price targets for Rite Aid or view Wall Street analyst' top-rated stocks.

Who are some of Rite Aid's key competitors?

Some companies that are related to Rite Aid include PetMed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), Progressive Care (RXMD), HealthWarehouse.com (HEWA), Dragon Jade International (DGJI), Dougherty's Pharmacy (MYDP), China Dasheng Biotechnology (CDBT) and Health Sciences Group (HESG).
View all of RAD's competitors.

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), (CELG), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and CVS Health (CVS).

Who are Rite Aid's key executives?

Rite Aid's management team includes the following people:

Ms. Heyward Rutledge Donigan B.A., Pres CEO & Director (Age 59, Pay $4.62M)
Mr. Matthew Schroeder, CFO & Exec. VP (Age 50, Pay $1.13M)
Mr. James Joseph Peters Jr., Chief Operating Officer (Age 48, Pay $558.62k)
Ms. Jocelyn Zazyczny Konrad, Exec. VP & Chief Pharmacy Officer (Age 50, Pay $1.25M)
Mr. Brian T. Hoover, Chief Accounting Officer (Age 55)
Mr. Justin L. Mennen, Exec. VP & Chief Information Officer (Age 39)
Byron Purcell, Sr. Director of Treasury Services & Investor Relations
Mr. Trent Kruse, Sr. VP of Investor Relations & Treasury
Mr. Paul D. Gilbert, Exec. VP, Gen. Counsel & Corp. Sec. (Age 53)
Ms. Susan K. Henderson, Chief Communications Officer & Sr. VP (Age 67)

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Creative Financial Designs Inc. ADV (0.00%).
View institutional ownership trends for Rite Aid.

Which institutional investors are buying Rite Aid stock?

RAD stock was acquired by a variety of institutional investors in the last quarter, including Creative Financial Designs Inc. ADV.
View insider buying and selling activity for Rite Aid or or view top insider-buying stocks.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $18.25.

How big of a company is Rite Aid?

Rite Aid has a market capitalization of $1.01 billion and generates $21.93 billion in revenue each year. The company earns $-452,170,000.00 in net income (profit) each year or $0.15 on an earnings per share basis. Rite Aid employs 29,840 workers across the globe.

What is Rite Aid's official website?

The official website for Rite Aid is www.riteaid.com.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]

This page was last updated on 1/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here